Clinical Trials Directory

Trials / Completed

CompletedNCT02324595

Minimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility Study

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Catholic University of the Sacred Heart · Academic / Other
Sex
Female
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Phase II multicentric study

Detailed description

The aim of this prospective Phase II multicentric study is to assess feasibility and early complications rate of "total laparoscopic/robotic" interval debulking surgery in patients with a clinical complete/partial response to neoadjuvant chemotherapy for advanced ovarian cancer.

Conditions

Interventions

TypeNameDescription
PROCEDURELaparoscopic interval debulking surgeryDiagnostic laparoscopy with a careful exploration of peritoneal cavity: if available a 5 mm "flexible tip" videolaparoscope will be used to explore all peritoneal recesses.For eligible patients,will be placed 3 5mm trocar in standard position for pelvic surgery:cytoreduction will consist in total/radical hysterectomy,bilateral salpingo-oophorectomy,radical omentectomy.If needed pelvic/upper peritonectomy will be performed:in these cases additional trocar can be placed in right or left subcostal spaces. All surgical procedure requested will have be carried out by laparoscopy/robotic or by laparotomy,in case of increased surgical risk or technical impossibility:the case will be registered as laparotomic conversion.At the end of surgical procedures residual tumor will be registered

Timeline

Start date
2013-12-01
Primary completion
2015-02-01
Completion
2016-02-01
First posted
2014-12-24
Last updated
2016-04-13

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT02324595. Inclusion in this directory is not an endorsement.